Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cholecystokinin and the hormone concept

    Research output: Contribution to journalReviewpeer-review

  2. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Free testosterone and cardiometabolic parameters in men: comparison of algorithms

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma marker for systemic inflammation is increased in Mexican Tarahumara following ultra-distance running

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Plasma volume contraction reduces atrial natriuretic peptide after four days of hypobaric hypoxia exposure

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Chromogranin A in cardiovascular endocrinology

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Bioactive adrenomedullin in plasma is associated with biventricular filling pressures in patients with advanced heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The antihypertensive actions of glucagon-like peptide-1 (GLP1) receptor agonists have been linked to the release of atrial natriuretic peptide (ANP) in mice. Whether a GLP1-ANP axis exists in humans is unknown. In this study, we examined 12 healthy young males in a randomized, controlled, double-blinded, single-day, cross-over study to evaluate the effects of a 2-h native GLP1 infusion. Plasma proANP concentrations were measured by an automated mid-region-directed proANP immunoassay and N-terminal pro B-type natriuretic peptide (BNP) on Roche Modular E170. Urine was collected for measurements of sodium excretion. Although GLP1 infusion increased the urinary sodium excretion markedly, there were no significant changes in either proANP or proBNP concentrations. When GLP1 infusion was stopped, sodium excretion declined rapidly. As proANP concentration reflects ANP secretion, our data could not confirm the existence of a GLP1-ANP axis in humans. Especially, the natriuretic effects of GLP1 seem unlikely to be mediated exclusively via ANP.

Original languageEnglish
JournalEndocrine Connections
Volume3
Issue number1
Pages (from-to)11-6
Number of pages6
ISSN2049-3614
DOIs
Publication statusPublished - 2014

ID: 44718568